Sirna Therapeutics
San Francisco
About Sirna Therapeutics
The scientific community considers RNA interference the breakthrough biological discovery of the decade with the potential to change how diseases are treated. Sirna Therapeutics is at the forefront of the effort to create RNAi- based therapies and leverage the vast potential of this technology to ultimately treat patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $86.9M
- Funding stage: M&A
- Last round: Series Unknown (Aug 2023)
- Ticker: nasdaq:RNAI
- Website: sirna.com
- Phone: (415)512-7200
Industries & Categories
Biotechnology, Information Technology, Medical
Canonical: https://fsome.com/organization/sirna-therapeutics-221513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.